Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London Kumar Jeetendra | January 5, 2021 Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase III PROVENT trial which will evaluate AstraZeneca’s long-acting antibody combination, AZD7442, for the potential prevention of COVID-19. The double-blind, placebo-controlled trial will include adult volunteers who have no history of COVID-19 and have an increased risk of infection, …
Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel Kumar Jeetendra | December 21, 2020 Waltham, Mass – December 21, 2020 – Nordic Capital and Astorg today announced an agreement to jointly acquire Cytel Inc. (“Cytel”), from New Mountain Capital. Cytel is one of the largest providers of statistical software and advanced analytics for clinical trial design and biometrics execution. Building on Cytel’s advanced software platform and leading biometrics services …
John Bell & Croyden celebrates key role of community pharmacists during covid-19 Kumar Jeetendra | December 16, 2020 London, UK – 16 December 2020 –John Bell & Croyden – holders of the Royal Warrant and pharmacists to Her Majesty the Queen – are celebrating the key role that community pharmacists have played during COVID-19. The renowned pharmacy emporium – who have kept their doors opened through two world wars and now a pandemic …
Sygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilities Kumar Jeetendra | December 16, 2020 Nottingham and Alderley Park, UK – 16th December 2020 – Life Science Newswire – Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical contract research organization, is strengthening its high-throughput screening (HTS) and translational oncology service-offerings by investing £3 million in new instrumentation and equipment. Sygnature’s Translational Oncology department at Alderley Park is currently …
Roche partnered with Moderna to Include Antibody Test in Covid-19 Vaccine Trials Kumar Jeetendra | December 14, 2020 Roche, Basel, Switzerland, announced a partnership with Moderna Inc., Cambridge, Mass, to utilize the Elecsys Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. This will facilitate the quantitative measurement of SARS-CoV-2 Compounds and help to establish a correlation between vaccine-induced protection and degrees of anti-receptor binding domain (RBD) antibodies. Significantly, Moderna’s vaccine triggers …
HiMedia’s Molecular Biology Division gets ICMR nod along with CE/IVD approvals for their COVID range of products Kumar Jeetendra | December 14, 2020 HiGenoMB®, the Molecular Biology Division of HiMedia Laboratories Pvt. Ltd. the leading Indian BioSciences manufacturer proudly announces that it has received the prestigious ICMR and CE/IVD approval for its COVID Range of Products. 1.Hi-PCR® Coronavirus (COVID-19) Multiplex Probe PCR Kits (MBPCR243) 2.HiPurA® Viral RNA Purification Kit (MB615) 3.HiPurA® Viral RNA Purification Kit – Magnetic Bead …
Arctoris appoints three experienced industry executives as members of its Advisory Board Kumar Jeetendra | December 10, 2020 Oxford, UK – 10 December 2020 – Life Science Newswire – Arctoris Ltd, an Oxford-based research company operating a fully automated drug discovery platform, has appointed three distinguished experts as members of its Advisory Board: Beth J Hoffman PhD, Professor Khusru Asadullah MD, and Stanley Lapidus. “We are delighted to see Dr Hoffman, Prof Asadullah …
Cytel Acquires HEOR Experts Purple Squirrel Economics Kumar Jeetendra | December 2, 2020 Waltham, MA, December 1, 2020 – Cytel Inc., a leading provider of advanced analytics for the life sciences industry, has announced the acquisition of Purple Squirrel Economics. This new deal will further expand the global reach of Cytel’s Health Economics Outcomes Research (HEOR) expertise, which spans the entirety of the clinical development journey – from …
Measurement of Cancer Biomarker Enrichment in Exosomes Kumar Jeetendra | November 24, 2020 Postnova Analytics reports that researchers from the University of Utah (Salt Lake City, USA) have used a novel combination of Asymmetrical Flow Field-Flow Fractionation and Centrifugal Field-Flow Fractionation to measure cancer biomarker enrichment in exosomes. Asymmetrical Flow Field-Flow Fractionation (AF4) and Centrifugal Field-Flow Fractionation (CF3) are high resolution separation techniques for fractionation of macromolecules and …
USFDA Approved Foundation Medicine’s FoundationOne®Liquid CDx, a Pan-Tumor Liquid Biopsy Genomic Test for Late Stage Cancer Patients now Available in India Kumar Jeetendra | November 19, 2020 Mumbai, 18 November 2020: Roche Products (India) Pvt. Ltd. (Roche Pharma India) announces the launch of FoundationOne®Liquid CDx, Foundation Medicine’s comprehensive pan-tumor liquid biopsy test for patients with solid tumors in India. US FDA approved the FoundationOne®Liquid CDx, a comprehensive genomic profiling (CGP) test on August 26. This is the first test that can analyze …
Dotmatics collaborates with LabVoice Kumar Jeetendra | November 14, 2020 Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced a new partnership with LabVoice to provide R&D scientists with the ability to record, access, and track data within an electronic laboratory notebook (ELN) using hands-free voice-assisted technology. The …
A-LabInsider launched an app to boost biotech businesses Kumar Jeetendra | November 12, 2020 Berlin, Germany – 12 November, 2020 – Life Science Newswire – A-LabInsider has created an application that lists all academic life science labs in Europe with an intelligence to filter through them to make it easier for small and medium biotech companies to discover labs and do business with them. The concept was to create …
